Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.16ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.16NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.48.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.48.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.48.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.48.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LR.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LR.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LF.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LF.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LF.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LB.1.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LB.1.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.64ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.64ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.64ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.64NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.44ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.44NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
JN.1.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used